Remove 2023 Remove Legal Remove Personality disorders
article thumbnail

Medical Journals Refuse to Retract Fraudulent Trial Reports That Omitted Suicidal Events in Children

Mad in America

O n 3 August 2023, I wrote to the editors of two medical journals and called for retraction of three fraudulent reports of placebo-controlled trials of depression drugs in children and adolescents. Copenhagen: Institute for Scientific Freedom 2023;Nov 14. This is fraud. Arch Gen Psychiatry 2006;63:332-9. 17 Gøtzsche PC.

article thumbnail

Part 4: Neurodiversity: New Paradigm, or Trojan Horse?

Mad in America

The same is true of attempts to reframe other diagnostic labels as ‘identities’—including the most contentious, ‘borderline personality disorder’ which, it is suggested, can be ‘destigmatised’ through ‘ neuroqueer feminism ’. Neuroqueer Feminism: Turning with Tenderness toward Borderline Personality Disorder. Johnson, M.

article thumbnail

Set, Setting, Forgetting: Silence on Abuse in Psychedelic Therapy Histories

Mad in America

The new drug application for MDMA-AT submitted by MAPS would have allowed MDMA legal use solely within MAPS’ proprietary psychotherapy protocol and only for individuals with a PTSD diagnosis. In 2023, Dryer resigned her medical license. Ingrascis impact on the field cannot be understated.